Abbott Molecular Inc.
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
Previously recorded as Vysis, Inc. (to 2013)
3
Ending by 2030
Sep 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Jan 21 to 28, 2027 · next Jan 21
- 1 fee due Feb 27, 2027The maintenance fee for Purification of nucleic acids using copper-titanium oxides (US 10,392,613) comes due Feb 27, 2027. Unpaid by Aug 27, 2027, it lapses early.
- 1 fee due Jun 29, 2027The maintenance fee for Quantitating high titer samples by digital PCR (US 9,222,886) comes due Jun 29, 2027. Unpaid by Dec 29, 2027, it lapses early.
- 3 fees due Jul 7 to 21, 2027 · next Jul 7
- 4 fees due Sep 3 to 22, 2027 · next Sep 3
- 1 fee due Nov 12, 2027The maintenance fee for Reaction vessel systems and methods and systems for using same (US 10,648,018) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.
Recent changes
- 3 terms have ended since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,814,788 | Liquid Level Sensor In force · High confidence | In force | High confidence | |
| US 10,689,685 | Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples In force · From the USPTO record | In force | From the USPTO record | |
| US 9,291,625 | Diagnostic Methods For Determining Prognosis Of Non-Small Cell Lung Cancer In force · High confidence | In force | High confidence | |
| US 8,631,953 | Closure for container for holding biological samples In force · High confidence | In force | High confidence | |
| US 9,090,948 | Primers and Probes for Detecting Human Papillomavirus and Human Beta Globin Sequences in Test Samples In force · High confidence | In force | High confidence | |
| US 9,222,886 | Quantitating high titer samples by digital PCR In force · From the USPTO record | In force | From the USPTO record | |
| US 9,085,808 | Materials and method for detecting cytomegalovirus (CMV) In force · From the USPTO record | In force | From the USPTO record | |
| US D802,156 | Diagnostic analyzer In force · From the USPTO record | In force | From the USPTO record | |
| US 9,469,877 | Materials and Methods for Diagnosis, Prognosis, Monitoring of Recurrence, and Assessment of Therapeutic/Prophylactic Treatment of Pancreatobiliary Cancer In force · High confidence | In force | High confidence | |
| US 10,774,376 | Quantitating high titer samples by digital PCR In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 53: 2 patents in force now held by others · 56 lapsed for an unpaid fee · 65 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 3 abandoned · 45 no status recorded